DDCI-01, a novel long acting phospdiesterase-5 inhibitor, attenuated monocrotaline-induced pulmonary hypertension in rats

DDCI-01, a novel long acting phospdiesterase-5 inhibitor, attenuated monocrotaline-induced pulmonary hypertension in rats

Pulmonary arterial hypertension is a progressive, malignant heart disease, characterized by pulmonary arteriole remodeling and increased pulmonary vascular resistance, which eventually leads to right heart failure. This study sought to evaluate the effects of a novel long-acting phospdiesterase-5 in...

Full description

Bibliographic Details
Main Authors:	Ailing Li, Zhongkai Zhu, Yangke He, Qian Dong, Dianyong Tang, Zhongzhu Chen, Wei Huang
Format:	Article
Language:	English
Published:	Wiley 2020-11-01
Series:	Pulmonary Circulation
Online Access:	https://doi.org/10.1177/2045894020939842

Similar Items

Notopterol Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rat
by: Lin Huang, et al.
Published: (2022-06-01)

Nicorandil attenuates monocrotaline-induced vascular endothelial damage and pulmonary arterial hypertension.
by: Makoto Sahara, et al.
Published: (2012-01-01)

Pulmonary vessel casting in a rat model of monocrotaline-mediated pulmonary hypertension
by: Zhongkai Zhu, et al.
Published: (2020-08-01)

Combined use of arginase II inhibitors and tadalafil for the correction of monocrotaline pulmonary hypertension
by: Ivan S. Koklin, et al.
Published: (2019-09-01)

Maprotiline Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats
by: Yi Tong, et al.
Published: (2018-09-01)

Aspirin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing the ERK/MAPK pathway
by: Hua Gao, et al.
Published: (2017-01-01)

Betaine Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats via Inhibiting Inflammatory Response
by: Jia-mei Yang, et al.
Published: (2018-05-01)

Transmembrane protein 16A/anoctamin 1 inhibitor T16A-A01 reversed monocrotaline-induced rat pulmonary arterial hypertension
by: Jianye Xie, et al.
Published: (2020-10-01)

Tadalafil, a Long-Acting Inhibitor of PDE5, Improves Pulmonary Hemodynamics and Survival Rate of Monocrotaline-Induced Pulmonary Artery Hypertension in Rats
by: Fusae Sawamura, et al.
Published: (2009-01-01)

Cannabidiol Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats
by: Olga Sadowska, et al.
Published: (2020-09-01)

Lodenafil treatment in the monocrotaline model of pulmonary hypertension in rats
by: Igor Bastos Polonio, et al.
Published: (2014-08-01)

The protective role of EP300 in monocrotaline-induced pulmonary hypertension
by: Lei Yang, et al.
Published: (2023-02-01)

Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension
by: Yi Tang, et al.
Published: (2022-04-01)

The beneficial effect of suramin on monocrotaline-induced pulmonary hypertension in rats.
by: Mohamed Izikki, et al.
Published: (2013-01-01)

Rosuvastatin, Sildenafil and Their Combination in Monocrotaline-Induced Pulmonary Hypertension in Rat
by: Jasińska-Stroschein Magdalena, et al.
Published: (2014-09-01)

Comparative analysis of age in monocrotaline-induced pulmonary hypertensive rats
by: Akiko Kawade, et al.
Published: (2021-09-01)

Early treatment with fumagillin, an inhibitor of methionine aminopeptidase-2, prevents Pulmonary Hypertension in monocrotaline-injured rats.
by: Daniel J Kass, et al.
Published: (2012-01-01)

Evaluating Opicapone as Add-on Treatment to Levodopa/DDCI in Patients with Parkinson’s Disease
by: Jost WH
Published: (2022-08-01)

Cannabidiol inhibits lung proliferation in monocrotaline-induced pulmonary hypertension in rats
by: Anna Krzyżewska, et al.
Published: (2023-03-01)

Fermented garlic extract ameliorates monocrotaline-induced pulmonary hypertension in rats
by: Byung Mun Park, et al.
Published: (2017-03-01)

Ameliorative Effects of Beetroot Juice Supplementation on Monocrotaline-Induced Pulmonary Hypertension in Rats
by: Masashi Tawa, et al.
Published: (2022-11-01)

Inhibition of Shp2 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats
by: Yusheng Cheng, et al.
Published: (2018-08-01)

Subchronic toxicity of the pulmonary hypertension model due to low-dose monocrotaline in rats
by: Vicente Benavides-Cordoba, et al.
Published: (2020-07-01)

Metabolic Changes Precede the Development of Pulmonary Hypertension in the Monocrotaline Exposed Rat Lung.
by: Olga Rafikova, et al.
Published: (2016-01-01)

STUDY OF THE PHARMACOLOGICAL ACTIVITY OF LOWMOLECULAR ARGINASE II SELECTIVE INHIBITOR USING A MODEL OF MONOCROTALINE-INDUCED PULMONARY HYPERTENSION
by: Liliya V. Korokina, et al.
Published: (2019-03-01)

Inhalation of the BK(Ca)-opener NS1619 attenuates right ventricular pressure and improves oxygenation in the rat monocrotaline model of pulmonary hypertension.
by: Marc Revermann, et al.
Published: (2014-01-01)

Activation of Nicotinic Acetylcholine α7 Receptor Attenuates Progression of Monocrotaline-Induced Pulmonary Hypertension in Rats by Downregulating the NLRP3 Inflammasome
by: Yan Deng, et al.
Published: (2019-02-01)

A potential model of systemic sclerosis with pulmonary hypertension induced by monocrotaline plus bleomycin
by: Xia Fang, et al.
Published: (2022-08-01)

Monocrotaline Induces Endothelial Injury and Pulmonary Hypertension by Targeting the Extracellular Calcium–Sensing Receptor
by: Rui Xiao, et al.
Published: (2017-04-01)

Saluisn-β contributes to endothelial dysfunction in monocrotaline-induced pulmonary arterial hypertensive rats
by: Yan Pan, et al.
Published: (2022-11-01)

Early progression of pulmonary hypertension in the monocrotaline model in males is associated with increased lung permeability
by: Olga Rafikova, et al.
Published: (2020-03-01)

Myocardial and anti-inflammatory effects of chronic bosentan therapy in monocrotaline-induced pulmonary hypertension
by: Dulce Fontoura, et al.
Published: (2014-04-01)

Beneficial Effect of Ocimum sanctum (Linn) against Monocrotaline-Induced Pulmonary Hypertension in Rats
by: Himanshu Meghwani, et al.
Published: (2018-04-01)

Effects of bone marrow-derived cells on monocrotaline- and hypoxia-induced pulmonary hypertension in mice
by: Vainchenker William, et al.
Published: (2007-01-01)

Influence of gender in monocrotaline and chronic hypoxia induced pulmonary hypertension in obese rats and mice
by: Balram Neupane, et al.
Published: (2020-06-01)

The Drug Derived Complexity Index (DDCI) Predicts Mortality, Unplanned Hospitalization and Hospital Readmissions at the Population Level.
by: Fabio Robusto, et al.
Published: (2016-01-01)

Forsythoside B Mitigates Monocrotaline-Induced Pulmonary Arterial Hypertension via Blocking the NF-κB Signaling Pathway to Attenuate Vascular Remodeling
by: Liu J, et al.
Published: (2024-03-01)

Preventive treatment with atorvastatin ameliorates endothelial dysfunction of small pulmonary arteries in monocrotaline-induced pulmonary hypertensive rats
by: Zhihong Lin, et al.
Published: (2017-08-01)

Cannabidiol Improves Antioxidant Capacity and Reduces Inflammation in the Lungs of Rats with Monocrotaline-Induced Pulmonary Hypertension
by: Anna Krzyżewska, et al.
Published: (2022-05-01)

Congestive Hepatopathy Secondary to Right Ventricular Hypertrophy Related to Monocrotaline-Induced Pulmonary Arterial Hypertension
by: Douglas Mesadri Gewehr, et al.
Published: (2021-11-01)